상세 보기
A Phase 2b, Randomized, Double-Blind, Placebo-Controlled Trial of Presatovir (GS-5806), a Novel Oral RSV Fusion Inhibitor, for the Treatment of Respiratory Syncytial Virus (RSV) in Hospitalized Adults
- Hanfelt-Goade, D.;
- Maimon, N.;
- Nimer, A.;
- Riviere, F.;
- Catherinot, E.;
- ... Jeong, S.;
- 외 21명
Citations
WEB OF SCIENCE
17- 제목
- A Phase 2b, Randomized, Double-Blind, Placebo-Controlled Trial of Presatovir (GS-5806), a Novel Oral RSV Fusion Inhibitor, for the Treatment of Respiratory Syncytial Virus (RSV) in Hospitalized Adults
- 저자
- Hanfelt-Goade, D.; Maimon, N.; Nimer, A.; Riviere, F.; Catherinot, E.; Ison, M.; Jeong, S.; Walsh, E.; Gafter-Gvili, A.; Nama, S.; Napora, P.; Chowers, M.; Bergeron, A.; Zeltser, D.; Moudgil, H.; Limaye, A. P.; Couturaud, F.; Nseir, W.; McKevitt, M.; Porter, D.; Jordan, R.; Guo, Y.; German, P.; Watkins, T. R.; Gossage, D. L.; Chien, J. W.; Falsey, A. R.
- 발행일
- 2018-05
- 유형
- Meeting Abstract
- 권
- 197